1613149-75-9

Upstream product

• 866605-96-1 (3R,4S,5S,6R)-2-(3-((tert-butyldiphenylsilyloxy)methyl)-4-chlorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol 
• 106-40-1 4-bromo-aniline 
• 1334297-69-6 (2-chloro-5-((2S,3S,4R,5R,6R)-3,4,5-tris(methoxymethoxy)-6-((methoxymethoxy)methyl)tetrahydro-2H-pyran-2-yl)phenyl)methanol 
• 1334297-68-5 tert-butyl(2-chloro-5-((2S,3S,4R,5R,6R)-3,4,5-tris(methoxymethoxy)-6-((methoxymethoxy)methyl)tetrahydro-2H-pyran-2-yl)benzyloxy)diphenylsilane 
• 866605-95-0 (5-bromo-2-chlorobenzyloxy)(tert-butyl)diphenylsilane 
• 32469-28-6 (3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one 
• 866605-97-2 (2S,3R,4R,5S,6R)-2-(3-((tert-butyldiphenylsilyloxy)methyl)-4-chlorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1334297-71-0 (2S,3S,4R,5R,6R)-2-(3-(bromomethyl)-4-chlorophenyl)-3,4,5-tris(methoxymethoxy)-6-((methoxymethoxy)methyl)-tetrahydro-2H-pyran 
• 1356964-48-1 C₁₆H₂₁BN₂O₄ 
• 345648-37-5 3-(4-bromophenyl)imidazolidine-2,4-dione 
• 111633-96-6 [3-(4-Bromo-phenyl)-ureido]-acetic acid ethyl ester 

Downstream Products

• 1334297-89-0 3-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)-1-methylimidazolidine-2,4-dione 

Relevant academic research and scientific papers

The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties

The sodium glucose co-transporter 2 (SGLT2) has received considerable attention in recent years as a target for the treatment of type 2 diabetes mellitus. This report describes the design, synthesis and structure-activity relationship (SAR) of C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties as novel SGLT2 inhibitors. Compounds 5p and 33b demonstrated high potency in inhibiting SGLT2 and high selectivity against SGLT1. The in vitro ADMET properties of these compounds will also be discussed.